Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;153(5&6):702-703.
doi: 10.4103/ijmr.IJMR_4925_20.

Heterogeneity in protocols for bronchoalveolar lavage & sub-genomic RNA evaluation in non-human primate studies of SARS-CoV-2 vaccine candidates' evaluation

Sanjay Kumar  1
Affiliations
Comment

Heterogeneity in protocols for bronchoalveolar lavage & sub-genomic RNA evaluation in non-human primate studies of SARS-CoV-2 vaccine candidates' evaluation

Sanjay Kumar. Indian J Med Res. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Comment in

  • Authors' response.
    Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete-Aich A, Panda S, Bhargava B. Mukhopadhyay L, et al. Indian J Med Res. 2021 May;153(5&6):703-704. doi: 10.4103/0971-5916.318735. Indian J Med Res. 2021. PMID: 34643572 Free PMC article. No abstract available.

Comment on

References

    1. Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete-Aich A, et al. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res. 2021;153:93–114. - PMC - PubMed
    1. Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, et al. A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates. bioRxiv. 2020 doi: 10.1101/2020.09.08.280818.
    1. Guebre-Xabier M, Patel N, Tian JH, Zhou B, Maciejewski S, Lam K, et al. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways 3 against SARS-CoV-2 challenge. bioRxiv. 2020 doi: 10.1101/2020.08.18.256578. - PMC - PubMed
    1. Yang J, Wang W, Chen Z, Lu S, Yang F, Bi Z, et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020;586:572–7. - PubMed
    1. Yadav P, Kumar S, Patil D, Mohandas S, Shete A, Bhati G, et al. Remarkable immunogenicity and protective efficacy of BBV152, an inactivated SARS-CoV-2 vaccine in Rhesus macaques. [accessed on October 29, 2020]. Available from: https://www.researchsquare.com/article/rs-65715/v1 .